During the past decade, American Oncology Network Vista Oncology Division conducted 2 clinical trials. In the 10-year time frame, 2 clinical trials started and 0 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 2 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

According to Clinical.Site data, the most researched conditions in "American Oncology Network Vista Oncology Division" are "Warm Antibody Autoimmune Hemolytic Anemia" (2 trials). Many other conditions were trialed in "American Oncology Network Vista Oncology Division" in a lesser frequency.

Most popular intervention types in "American Oncology Network Vista Oncology Division" are "Drug" (2 trials). Other intervention types were less common.

The name of intervention was led by "Fostamatinib disodium" (2 trials) and "Placebo" (1 trials). Other intervention names were less common.

The vast majority of trials in "American Oncology Network Vista Oncology Division" are 2 trials for "All" genders.

Currently, there are NaN active trials in "American Oncology Network Vista Oncology Division". undefined are not yet recruiting, undefined are recruiting, undefined are Active, not recruiting, and 1 are Enrolling by invitation. In total, there were 1 completed trials in American Oncology Network Vista Oncology Division, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in American Oncology Network Vista Oncology Division, 0 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 2 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".